By: Dr. Donna Powell & Dr. Renee M. Marchioni Beery with Gastro MD October is ‘Liver Cancer Awareness Month’, a time to spread awareness about this disease that impacts one of the largest organs...

What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers...

A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver...

A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer. Researchers at UT Southwestern Medical Center studied...

Chronic hepatitis B virus (HBV) can progress to cirrhosis and hepatocellular carcinoma (HCC). A study published in The Journal of Molecular Diagnostics describes a new HBV assay that offers advantages...

Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus...

The Northern Mariana Islands are a U.S. commonwealth (CNMI) in the Pacific Ocean. It consists of 14 islands with Saipan being the largest. The World Health Organization announced recently that the island...

The U.S. Food and Drug Administration  expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously...

A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus (HCV) two years after the United States Preventive Services Task Force (USPSTF) recommended...

The first report of the Pan American Health Organization (PAHO) on viral hepatitis reveals the enormous scale of this silent epidemic in the Americas,  and advocates an organized response by the countries...